Saeid Amiri Zadeh Fard | Microbiology | Best Researcher Award

Dr. Saeid Amiri Zadeh Fard | Microbiology | Best Researcher Award

Shiraz University of Medical Sciences | Iran

Dr. Saeid Amiri Zadeh Fard is a distinguished biomedical researcher specializing in virology and biotechnology. With extensive experience in viral suppression techniques, particularly short hairpin RNA (shRNA)-based strategies, his work aims to develop innovative therapeutic solutions for viral and immunological diseases. Known for his meticulous research approach and organizational skills, he has made significant contributions to biomedical engineering and immunotherapy.

Professional profile👤

Google Scholar

ORCID

Strengths for the Awards✨

  • Extensive Research Experience:

    • Over two decades of experience in biomedical research, with a focus on virology, RNA analysis, and immunological diseases.

    • Leadership roles as a Principal Investigator, Research Coordinator, and Senior Researcher.

  • Significant Contributions to Scientific Knowledge:

    • Multiple peer-reviewed publications in well-regarded journals.

    • Research in shRNA-based antiviral therapies and autophagy in liver fibrosis, which have important clinical implications.

  • Teaching and Mentorship:

    • Experience teaching undergraduate and graduate students in microbiology, virology, medical biotechnology, and related fields.

    • Conducted training sessions in advanced molecular biology techniques such as PCR, ELISA, gene cloning, and viral culture methods.

  • Technical Expertise:

    • Skilled in molecular biology, viral diagnostics, and gene therapy techniques.

    • Proficient in specialized software for bioinformatics and data analysis

Education 🎓

Dr. Amiri Zadeh Fard holds a Ph.D. in Medical Virology from Shiraz University of Medical Sciences (2018-2023). He also earned an M.Sc. in Bacteriology from Shahre-Kord University of Medical Sciences (2016-2018), a B.Sc. from Shiraz Azad University (2011-2016), and an Associate Degree from Bandar Abbas University of Medical Sciences (1995-1998).

Experience 🌟

Dr. Amiri Zadeh Fard has held key research positions at the Gastroenterohepathology Research Center, Iran, since 2008. He has served as Principal Investigator, Research Coordinator, and Senior Researcher, significantly enhancing research efficiency through advanced viral analysis methods. Additionally, his role as a Laboratory Instructor and Technician has allowed him to mentor students and improve laboratory processes.

Research Interests On Microbiology🔬

His research focuses on biomedical engineering, virology, and biotechnology, particularly on shRNA-mediated viral suppression. His expertise spans DNA and RNA analysis, viral culture, gene cloning, and the development of novel therapeutic interventions for immunological diseases.

Awards & Honors 🏆

Dr. Amiri Zadeh Fard has received multiple accolades for his pioneering research in virology and biotechnology. His contributions to shRNA-based antiviral strategies have been widely recognized in the scientific community, earning him invitations as a reviewer for prestigious journals such as Clinica Chimica Acta.

Publications 📚

  • Therapeutic and Adverse Effects of Glucantime Used for Treatment of Cutaneous Leishmaniasis
    Authors: AS Beheshti M, Ghotbi Sh
    Year: 2007
    Citations: 25

  • Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia
    Authors: S Haghpanah, N Cohan, M Bordbar, A Bazrafshan, M Karimi, S Zareifar, …
    Year: 2021
    Citations: 12

  • Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran
    Authors: KB Lankarani, B Honarvar, HM Vardanjani, A Kharmandar, MM Gouya, …
    Year: 2020
    Citations: 11

  • Value of serological biomarker panel in diagnosis of atrophic gastritis and Helicobacter pylori Infection
    Authors: GR Sivandzadeh, SAZ Fard, A Zahmatkesh, MH Anbardar, KB Lankarani
    Year: 2023
    Citations: 7

  • Predictors of death in the liver transplantation adult candidates: an artificial neural networks and support vector machine hybrid-based cohort study
    Authors: KB Lankarani, B Honarvar, FS Pour, M Bagherpour, A Erjaee, …
    Year: 2022
    Citations: 4

  • Sustained Suppression of Fusion Gene‑mediated Human Respiratory Syncytial Virus Load by shRNA‑based Therapeutics
    Authors: ABB Amiri Zadeh S, Haniyeh Abuei, Ali Farhadi, Gholamreza Rafiei …
    Year: 2023
    Citations: 3*

  • Unlocking therapeutic potential: enhanced shRNA delivery with Tat peptide in the human respiratory Syncytial Virus Treatment
    Authors: SAZ Fard, H Abuei, AB Behbahani, GR Dehbidi, F Zare, M Nejabat, …
    Year: 2024
    Citations: 2

  • The Potential Role of Autophagy in Progression of Liver Fibrosis in Chronic Hepatitis B Patients Receiving Antiviral Treatment: A Brief Report
    Authors: KB Lankarani, A Sadidoost, M Fattahi, SA Fard, P Mokarram
    Year: 2024
    Citations: 1

  • Short hairpin RNA-mediated matrix gene silencing of human respiratory syncytial virus as a potent antiviral strategy
    Authors: ZAABB Saeid Amiri Zadeh Fard, Haniyeh Abuei, Ali Farhadi, Gholamreza …
    Year: 2023
    Citations: 1

  • Helicobacter pylori infection and inflammatory bowel disease: is there a link?
    Authors: M Nejabat, SAZ Fard, A Safarpour, SA Jirandeh
    Year: 2018
    Citations: 1

Conclusion 🎯

Dr. Saeid Amiri Zadeh Fard is a passionate researcher dedicated to advancing virology and biomedical engineering. His expertise in RNA-based therapeutics and extensive contributions to scientific research make him a valuable asset to the field. His leadership in research coordination and laboratory management continues to drive impactful discoveries in viral immunotherapy.

Fizza Khalid | microbiology | Best Researchrer Award

Dr. Fizza Khalid | microbiology | Best Researcher Award

clinical scientist at Dr Sulaiman Al-Habib Medical Diagnostic Laboratory , Saudi Arabia

Dr. Fizza Khalid is a dedicated microbiologist with extensive expertise in laboratory research, antimicrobial resistance, and clinical microbiology. With a Ph.D. in Medical Microbiology from the University of Health Sciences, Lahore, she has a proven track record of characterizing drug-resistant bacteria and developing innovative treatment strategies. Currently, she is the Deputy Head of the Clinical Research Committee and a Specialized Lab Supervisor at MD Lab, Dr. Sulaiman AlHabib Medical Group, Saudi Arabia. Dr. Khalid is passionate about advancing microbiological research to improve healthcare outcomes and has published several impactful studies in leading international journals.

Profile

ORCID

Educational

  • Ph.D. in Medical Microbiology (2016–2023) – University of Health Sciences, Lahore
    Thesis: Characterization of Locally Isolated Acinetobacter baumannii Strains for Drug Resistance and Biofilm Formation
  • M.Phil. in Medical Microbiology (2012–2014) – University of Health Sciences, Lahore
    Thesis: In-vitro Efficacy of Polymyxin B with Rifampin, Colistin, and Doxycycline Against Extensively Drug Resistant Acinetobacter baumannii
  • M.Sc. in Medical Technology (2008–2010) – University of Health Sciences, Lahore
    Thesis: Frequency of Extended Spectrum Beta Lactamase Enzymes in the Clinical Isolates of Salmonella Typhi
  • B.Sc. in Medical Laboratory Technology (2005–2007) – University of Health Sciences, Lahore

Professional Experience

Dr. Fizza Khalid currently serves as the Deputy Head of the Clinical Research Committee and Specialized Lab Supervisor in Microbiology at MD Lab, Dr. Sulaiman AlHabib Medical Group, Saudi Arabia. In her role, she leads clinical microbiology operations, collaborates with healthcare professionals, ensures regulatory compliance, and conducts research presented at international conferences. Previously, she was a Senior Lab Technologist at the same group, where she developed standard operating protocols, performed clinical microbiology analysis, and ensured testing quality and safety compliance. Throughout her career, Dr. Khalid has mentored junior researchers, promoted clinical research, and conducted workshops to enhance scientific study design and writing skills.

Research Interests

Dr. Khalid’s research focuses on antimicrobial resistance, particularly in Acinetobacter baum                                                                                             annii and Salmonella Typhi, biofilm formation, and the effectiveness of novel treatment strategies against drug-resistant bacterial strains. She has a keen interest in developing antimicrobial agents, studying bacterial genotyping, and investigating synergistic antibiotic combinations to combat multidrug-resistant pathogens. Her research contributes to understanding the molecular mechanisms of resistance and finding practical applications for improving patient care in clinical settings.

Author Metrics

  • Published Papers: 14 peer-reviewed articles, including journals such as Clinica Chimica Acta, JPMA, Scientific Reports, and Annals of Clinical Microbiology and Antimicrobials.
  • Citations: Her work has been widely cited in the fields of antimicrobial resistance and biofilm research.
  • H-index: Reflects her contributions to microbiology, particularly in research related to Acinetobacter baumannii and Salmonella Typhi.

Publication

Conclusion

Fizza Khalid presents an excellent case for the Best Researcher Award in medical microbiology, with notable strengths in antibiotic resistance research, an impressive publication record, and practical lab expertise. Her leadership role in facilitating junior researchers and fostering a culture of research also speaks to her broader contribution to the scientific community. With a few targeted improvements, such as securing international collaborations and focusing her research scope, she can further strengthen her candidacy for the award.

In conclusion, Khalid’s achievements in medical microbiology, particularly her work on MDR pathogens, make her a strong contender for the Best Researcher Award, demonstrating both scientific excellence and leadership in her field.